2 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid TumorsNeoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, carcinoma, epithelial neoplasm, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm, transitional cell carcinomaRecruitingPhase 12026-07-27NCT07518043
SKB264 in Combination With Pembrolizumab in Subjects With Selected Solid TumorsSolid TumorActive, not recruitingPhase 22025-10-14NCT05642780